embecta to Report Fiscal Second Quarter Financial Results
Rhea-AI Summary
embecta (Nasdaq: EMBC) will report fiscal second quarter 2026 results and host a live conference call and webcast on May 5, 2026 at 8:00 a.m. ET. A replay will be available beginning at 11:00 a.m. ET on the embecta investor relations website and archived for one year.
AI-generated analysis. Not financial advice.
Positive
- None.
Negative
- None.
News Market Reaction – EMBC
On the day this news was published, EMBC gained 2.14%, reflecting a moderate positive market reaction. Our momentum scanner triggered 2 alerts that day, indicating moderate trading interest and price volatility. This price movement added approximately $11M to the company's valuation, bringing the market cap to $540.68M at that time.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
Peers show mixed moves with several declines (e.g., STAA -3.15%, KMTS -1.76%) and BLFS slightly higher, suggesting stock-specific trading rather than a clear sector trend.
Previous Earnings date Reports
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Jan 22 | Earnings date announcement | Neutral | -9.4% | Announcement of upcoming fiscal Q1 2026 results and investor call logistics. |
| Nov 11 | Earnings date announcement | Neutral | +2.0% | Set date for Q4 and full-year 2025 results and guidance conference call. |
Prior earnings-date announcements saw mixed reactions with an average move of -3.73%, including one notable single-day decline.
Over recent quarters, embecta has consistently pre-announced its earnings dates with similar webcast and replay arrangements. The last two earnings-date releases on Nov 11, 2025 and Jan 22, 2026 led to price moves of +1.97% and -9.44%, respectively, averaging -3.73%. Today’s notice of the fiscal Q2 2026 call follows the same communication pattern, signaling continuity in how the company prepares investors for upcoming results and operational updates.
Historical Comparison
In the past two earnings-date notices, embecta’s stock moved an average of -3.73%. Today’s pre-call setup continues that pattern of modest, event-driven trading.
Market Pulse Summary
This announcement sets the timetable for embecta’s fiscal Q2 2026 financial results, with a conference call at 8:00 a.m. ET on May 5, 2026 and a replay available for one year. It continues the company’s established practice of advance earnings-date communication. Investors may focus on how upcoming results and the operational update relate to prior filings and board decisions when assessing the company’s ongoing transformation and leverage profile.
AI-generated analysis. Not financial advice.
PARSIPPANY, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, will host a conference call to discuss its fiscal second quarter 2026 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Tuesday, May 5, 2026.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 5, 2026, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global company that is advancing its 100-year legacy in insulin delivery to become a broad-based medical supplies company, helping to improve lives through innovative solutions, partnerships, and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media Christian Glazar Sr. Director, Corporate Communications 908-821-6922 Contact Media Relations | Investors Pravesh Khandelwal VP, Head of Investor Relations 551-264-6547 Contact IR |
